Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...
Ugur Sahin; Chief Executive Officer, Member of the Management Board; Biontech SE Oezlem Tuereci; Chief Medical Office, Member of the Management Board; Biontech SE Welcome to BioNTech's fourth ...
CORONA salgınına karşı geliştirdikleri mRNA tabanlı aşı ile dünyanın gündemine gelen ve Almanya’yı, Türkler’i gururlandıran BioNTech firmasının Türk yöneticileri Dr. Uğur Şahin ile eşi Özlem Türeci, b ...
Hosted on MSN10mon
What's Going With BioNTech Stock On Monday?We look forward to providing more updates this year across our oncology portfolio, including our bispecific antibody and ADC programs,” said Ugur Sahin, CEO and Co-Founder of BioNTech.
The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings Call. I would like to hand the call over to Michael Horowicz, Director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback